CONCLUSION: Oral nicotinamide (non-flush vitamin B3) 500 mg twice daily was safe and effective in reducing the rates of new nonmelanoma skin cancers and actinic keratoses in high-risk patients. “A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.” N Continue reading Non-Melanoma Skin Cancer Prevention with Nicotinamide (Vitamin B-3)
The post Non-Melanoma Skin Cancer Prevention with Nicotinamide (Vitamin B-3) appeared first on .